Investment Stage

Focus Areas

About Investor

Daniel Allen is a Principal at Unorthodox Ventures based in Tel Aviv, where he focuses on biotechnology investments. He primarily supports Pre-seed, Seed, and Series A companies developing novel therapeutic, diagnostic, and life sciences technologies. Daniel typically invests between $250,000 and $1.5 million, with an average check size of approximately $1 million. His scientific background allows him to evaluate complex technologies and identify promising innovations within the biotech ecosystem. He is particularly interested in startups with strong research foundations and clear paths toward commercialization. Founders building breakthrough healthcare and life sciences solutions may find him a valuable strategic partner.